GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$140.89
-1.28 (-0.90%)
At Close: Apr 18, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Golden Star

Ticker Date Change Price
FTSL Apr 16 0.304% $46.08
FCN Apr 16 0.0096% $207.62
ELV Apr 16 3.59% $506.97
ITCI Apr 05 5.20% $68.44
AKR Apr 05 1.33% $16.53
SARK Mar 28 16.44% $26.88
ARCC Mar 25 1.49% $20.12
STT Mar 19 0.578% $72.62
BK Mar 19 0.0181% $55.24
LNC Mar 18 0.221% $27.17
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT